LYELLyell Immunopharma, Inc.

Nasdaq lyell.com


$ 2.62 $ 0.07 (2.76 %)    

Wednesday, 15-May-2024 15:59:58 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.61
$ 2.71
$ 2.61 x 600
$ 2.62 x 351
$ 2.52 - $ 2.71
$ 1.32 - $ 3.97
493,040
na
663.6M
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-lyell-immunopharma-maintains-6-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $6 pric...

 lyell-immunopharma-q1-sales-3000k-down-from-65000k-yoy

Lyell Immunopharma (NASDAQ:LYEL) reported $3.000 thousand in sales this quarter. This is a 95.38 percent decrease over sales of...

 live-nation-entertainment-groupon-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 argan-reports-upbeat-earnings-joins-coupang-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sh...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 blackberry-nurix-therapeutics-tesla-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 on-wednesday-february-28-2024-lyell-immunopharma-reported-q4-adjusted-eps-017-beats-023-estimate-sales-1300k-down-from-4839m-yoy

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-maintains-buy-on-lyell-immunopharma-lowers-price-target-to-6

HC Wainwright & Co. analyst Mitchell Kapoor maintains Lyell Immunopharma (NASDAQ:LYEL) with a Buy and lowers the price t...

 why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Longboard Pharmaceuticals, Inc.

 why-beyond-air-shares-are-trading-lower-by-around-37-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

 why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

 why-lyell-immunopharma-shares-are-rising-today

Lyell Immunopharma, Inc. (NASDAQ: LYEL) shares are trading higher after the company announced that the U.S.

 lyell-immunopharma-receives-fda-orphan-drug-designation-for-lyl845-for-the-treatment-of-melanoma

Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell ther...

 hc-wainwright--co-maintains-buy-on-lyell-immunopharma-lowers-price-target-to-8

HC Wainwright & Co. analyst Mitchell Kapoor maintains Lyell Immunopharma (NASDAQ:LYEL) with a Buy and lowers the price t...

 lyell-immunopharma--reports-q3-2023-results-cash-cash-equivalents-and-marketable-securities-as-of-september-30-2023-were-5982m

Extended funding of operations into 2027 by prioritizing investment in core clinical candidates and research platform value dri...

 lyell-immunopharma-presentations-at-sitc-highlight-new-nonclinical-data-on-product-candidates-and-innovative-technology-to-shorten-til-manufacturing

Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell ther...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION